Cytokinetics Inc.

Related Content

News | Heart Failure
Additional Data From SEQUOIA-HCM Presented at HFSA Annual Scientific Meeting

Sept. 30, 2024 — Cytokinetics, Inc. recently announced that additional analyses synthesizing data from SEQUOIA-HCM ...

Home October 02, 2024
arrow
Lahey Health Medical Center Investigator Leads Phase 3 trial demonstrating novel therapy enhances exercise capacity, improves symptoms in patients obstructive HCM
News | Cardiovascular Clinical Studies
New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy

May 14, 2024 — One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the ...

Home May 14, 2024
arrow
News
Cytokinetics Phase IIa Clinical Trial Evaluates Myosin Activator for Heart Failure

April 13, 2007 — Cytokinetics Inc. announced yesterday the initiation of Phase II clinical trials program evaluating CK ...

Home April 11, 2007
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now